Display options
Share it on

Neth Heart J. 2013 Oct;21(10):449-55. doi: 10.1007/s12471-013-0447-2.

The first year of the Venlo percutaneous coronary intervention program: procedural and 6-month clinical outcomes.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

K A Mol, B M Rahel, F Eerens, S Aydin, R P Th Troquay, J G Meeder

Affiliations

  1. Department of Cardiology, VieCuri Medical Center Venlo, Tegelseweg 210, 5912BL, Venlo, the Netherlands, [email protected].

PMID: 23975617 PMCID: PMC3776073 DOI: 10.1007/s12471-013-0447-2

Abstract

OBJECTIVES: Analysis of the first results of off-site percutaneous coronary interventions (PCI) and fractional flow reserve (FFR) measurements at VieCuri Medical Centre for Northern Limburg in Venlo.

BACKGROUND: Off-site PCI is accepted in the European and American Cardiac Guidelines as the need for PCI increases and it has been proven to be a safe treatment option for acute coronary syndrome.

METHODS: Retrospective cohort study reporting characteristics, PCI and FFR specifications, complications and 6-month follow-up for all consecutive patients from the beginning of off-site PCI in Venlo until July 2012. If possible, the data were compared with those of Medical Centre Alkmaar, the first off-site PCI centre in the Netherlands.

RESULTS: Of the 333 patients, 19 (5.7 %) had a procedural complication. At 6 months, a major adverse cardiovascular event (MACE) occurred in 43 (13.1 %) patients. There were no deaths or emergency surgery related to the PCI or FFR procedures. There was no significant difference in occurrence of a MACE or adverse cerebral event between the Alkmaar and Venlo population in the 30-day follow-up.

CONCLUSION: This study demonstrates off-site PCI at VieCuri Venlo to have a high success rate. Furthermore, there was a low complication rate, low MACE and no procedure-related mortality.

References

  1. J Invasive Cardiol. 2002 Feb;14(2):72-9 - PubMed
  2. Am J Cardiol. 2008 Jan 1;101(1):53-7 - PubMed
  3. Circulation. 2002 Oct 29;106(18):2346-50 - PubMed
  4. J Am Coll Cardiol. 2011 Dec 6;58(24):e44-122 - PubMed
  5. Am J Ther. 2011 Mar-Apr;18(2):e22-8 - PubMed
  6. Circulation. 2013 Jan 29;127(4):e362-425 - PubMed
  7. Am J Cardiol. 2005 May 1;95(9):1091-3 - PubMed
  8. Eur Heart J. 2012 Oct;33(20):2569-619 - PubMed
  9. Int J Cardiol. 2009 Feb 6;132(1):59-65 - PubMed
  10. Circ Cardiovasc Interv. 2012 Feb 1;5(1):62-8 - PubMed
  11. J Am Coll Cardiol. 2003 Jan 1;41(1):26-32 - PubMed
  12. Am Heart J. 2004 Oct;148(4):676-83 - PubMed
  13. J Am Coll Cardiol. 2006 Apr 18;47(8):1713-21 - PubMed
  14. Circulation. 2001 Jun 19;103(24):3019-41 - PubMed
  15. Am Heart J. 2006 Nov;152(5):888-95 - PubMed
  16. Circulation. 1987 Jul;76(1):142-54 - PubMed
  17. Heart. 2005 Dec;91 Suppl 6:vi1-27 - PubMed
  18. N Engl J Med. 2009 Jan 15;360(3):213-24 - PubMed
  19. J Invasive Cardiol. 2012 Jul;24(7):309-15 - PubMed
  20. Crit Pathw Cardiol. 2005 Jun;4(2):98-106 - PubMed
  21. JAMA. 2004 Oct 27;292(16):1961-8 - PubMed
  22. Catheter Cardiovasc Interv. 2007 Mar 1;69(4):471-8 - PubMed
  23. J Am Coll Cardiol. 2005 Dec 6;46(11):2004-9 - PubMed
  24. Eur Heart J. 2001 Sep;22(18):1733-40 - PubMed
  25. JAMA. 2002 Apr 17;287(15):1943-51 - PubMed
  26. Circulation. 1988 Aug;78(2):486-502 - PubMed
  27. J Am Coll Cardiol. 1999 Sep;34(3):674-80 - PubMed

Publication Types